NewsCoronavirus

Actions

FDA tells J&J to toss 60M doses made at Baltimore plant, allows release of 10M doses

Johnson & Johnson vaccine
Posted at 10:34 AM, Jun 11, 2021
and last updated 2021-06-11 18:43:19-04

The FDA said Friday that it would allow 10 million doses of Johnson & Johnson's COVID-19 vaccine made in a troubled Baltimore plant to be distributed but ordered that an additional 60 million doses must be discarded because of possible contamination.

The FDA says the 10 million doses made by Emergent BioSolutions should be distributed with a warning that states that it cannot guarantee the company followed proper manufacturing processes.

Emergent BioSolutions had been producing doses of both the Johnson & Johnson and AstraZeneca vaccine earlier this year. However, the company said in March that one batch of the J&J drug "did not meet quality standards."

The New York Times reports that the factory conflated the ingredients in the AZ and J&J vaccines.

This story is breaking and will be updated.